Cointime

NuvOx Pharma

company

About

NuvOx Pharma is developing a nanotechnology for oxygen delivery, DDFPe, which is a best-in-class drug that is Phase II ready in stroke.

  • 11 - 50

Highlights

Total Funding Amount
$2.30M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

NuvOx Pharma is developing a is developing a platform of drugs that, upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ib ready).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2.30M
NuvOx Pharma has raised a total of $2.30M in funding over 2 rounds. Their latest funding was raised on Jul 14, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 14, 2018 Grant $2M 1 National Institutes of Health — Detail
Nov 1, 2016 Grant $300K 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
NuvOx Pharma is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท